Vijaya Diagnostic Centre's Stock Sees Dip, But Remains Strong in Healthcare Industry
Vijaya Diagnostic Centre's stock has recently seen a dip of -5.24%, underperforming the sector by -7.48%. However, the company has been consistently outperforming the sector in the past month, with a 24.84% increase in its price. MarketsMojo has given a 'Buy' call for the stock, indicating a positive trend.
Vijaya Diagnostic Centre, a leading player in the hospital and healthcare services industry, has recently seen a dip in its stock price. On November 25th, 2024, the company's stock fell by -5.24%, underperforming the sector by -7.48%. However, this should not be a cause for concern for investors as the stock has been performing well in the past month, with a 24.84% increase in its price.
Despite the recent dip, MarketsMOJO has given a 'Buy' call for Vijaya Diagnostic Centre's stock. This is a positive sign for investors, as the company has been consistently outperforming the sector, which has seen a gain of only 2.24%.
The stock's intraday high was Rs 1242.6, showing a 3.18% increase, while the intraday low was Rs 1139.35, a -5.39% decrease. This indicates that the stock has been volatile, but it is currently trading higher than its 5 day, 20 day, 50 day, 100 day, and 200 day moving averages. This is a good sign for investors, as it shows a positive trend in the company's stock price.
It is also worth noting that Vijaya Diagnostic Centre's stock has fallen after three consecutive days of gains, which could be seen as a trend reversal. However, this should not be a cause for concern, as the stock has been performing well in the past month.
In comparison to the Sensex, Vijaya Diagnostic Centre's stock has underperformed in the past day, with a -5.77% decrease, while the Sensex has seen a 1.48% increase. However, in the past month, the company's stock has outperformed the Sensex, which has only seen a 1.12% increase.
In conclusion, despite the recent dip in its stock price, Vijaya Diagnostic Centre has been performing well in the past month and has received a 'Buy' call from MarketsMOJO. With a positive trend in its stock price and outperforming the sector, the company remains a strong player in the hospital and healthcare services industry.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
